Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
Want to see IN:KREBSBIO full AI Analyst Report?
Total Valuation
Krebs Biochemicals & Industries Ltd. has a market cap or net worth of ₹1.40B. The enterprise value is ₹3.65B.
Market Cap₹1.40B
Enterprise Value₹3.65B
Share Statistics
Krebs Biochemicals & Industries Ltd. has 21,560,587 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,560,587
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Krebs Biochemicals & Industries Ltd.’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -10.65%.
Return on Equity (ROE)0.10
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-10.65%
Return on Capital Employed (ROCE)-0.24
Revenue Per Employee1.24M
Profits Per Employee-886.55K
Employee Count191
Asset Turnover0.15
Inventory Turnover3.02
Valuation Ratios
The current PE Ratio of Krebs Biochemicals & Industries Ltd. is ―. Krebs Biochemicals & Industries Ltd.’s PEG ratio is 0.14.
PE Ratio―
PS Ratio3.61
PB Ratio-0.53
Price to Fair Value-0.53
Price to FCF-7.04
Price to Operating Cash Flow-82.38
PEG Ratio0.14
Income Statement
In the last 12 months, Krebs Biochemicals & Industries Ltd. had revenue of 237.32M and earned -169.33M in profits. Earnings per share was -7.85.
Revenue237.32M
Gross Profit65.30M
Operating Income-118.73M
Pretax Income-169.33M
Net Income-169.33M
EBITDA-54.50M
Earnings Per Share (EPS)-7.85
Cash Flow
In the last 12 months, operating cash flow was -16.76M and capital expenditures -20.52M, giving a free cash flow of -37.27M billion.
Operating Cash Flow-16.76M
Free Cash Flow-37.27M
Free Cash Flow per Share-1.73
Dividends & Yields
Krebs Biochemicals & Industries Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.51
52-Week Price Change-25.03%
50-Day Moving Average61.14
200-Day Moving Average64.12
Relative Strength Index (RSI)60.02
Average Volume (3m)726.00
Important Dates
Krebs Biochemicals & Industries Ltd. upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMay 21, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Krebs Biochemicals & Industries Ltd. as a current ratio of 0.09, with Debt / Equity ratio of -138.15%
Current Ratio0.09
Quick Ratio0.03
Debt to Market Cap2.62
Net Debt to EBITDA-41.23
Interest Coverage Ratio-1.68
Taxes
In the past 12 months, Krebs Biochemicals & Industries Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Krebs Biochemicals & Industries Ltd. EV to EBITDA ratio is -56.96, with an EV/FCF ratio of -25.49.
EV to Sales13.08
EV to EBITDA-56.96
EV to Free Cash Flow-25.49
EV to Operating Cash Flow-34.47
Balance Sheet
Krebs Biochemicals & Industries Ltd. has ₹1.27M in cash and marketable securities with ₹2.19B in debt, giving a net cash position of -₹2.19B billion.
Cash & Marketable Securities₹1.27M
Total Debt₹2.19B
Net Cash-₹2.19B
Net Cash Per Share-₹101.72
Tangible Book Value Per Share-₹75.58
Margins
Gross margin is 64.08%, with operating margin of -50.03%, and net profit margin of -71.35%.
Gross Margin64.08%
Operating Margin-50.03%
Pretax Margin-71.35%
Net Profit Margin-71.35%
EBITDA Margin-22.97%
EBIT Margin-50.03%
Analyst Forecast
The average price target for Krebs Biochemicals & Industries Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-45.21%
EPS Growth Forecast37.10%